Huma has raised $80 million in fourth-round financing that will go in part towards rolling out a new platform that can be used by developers to create disease management tools.
Amazon has launched a health monitoring programme in partnership with Omada Health that aims to identify people who may be eligible for enrolment into the latter’s disease
Juli, an artificial intelligence-powered platform to help people manage chronic health conditions, has been shown to improve outcomes in a pair of randomised clinical tria
Huma Therapeutics has been granted Class II clearance from the FDA for its Software-as-a-Medical-Device (SaMD) disease management platform, dramatically expanding the rang
Hard on the heels of the official launch of its digital disease management platform, Aptar Pharma has secured a partnership with Italian drugmaker Chiesi to deploy it in support of patients